Machine learning-based prediction of COVID-19 diagnosis based on symptoms.
Ontology highlight
ABSTRACT:
SUBMITTER: Zoabi Y
PROVIDER: S-EPMC7782717 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Publications
Machine learning-based prediction of COVID-19 diagnosis based on symptoms.
Zoabi Yazeed Y Deri-Rozov Shira S Shomron Noam N
NPJ digital medicine 20210104 1
Effective screening of SARS-CoV-2 enables quick and efficient diagnosis of COVID-19 and can mitigate the burden on healthcare systems. Prediction models that combine several features to estimate the risk of infection have been developed. These aim to assist medical staff worldwide in triaging patients, especially in the context of limited healthcare resources. We established a machine-learning approach that trained on records from 51,831 tested individuals (of whom 4769 were confirmed to have CO ...[more]
Similar Datasets
Project description:COVID-19 is a worldwide epidemic, as announced by the World Health Organization (WHO) in March 2020. Machine learning (ML) methods can play vital roles in identifying COVID-19 patients by visually analyzing their chest x-ray images. In this paper, a new ML-method proposed to classify the chest x-ray images into two classes, COVID-19 patient or non-COVID-19 person. The features extracted from the chest x-ray images using new Fractional Multichannel Exponent Moments (FrMEMs). A parallel multi-core computational framework utilized to accelerate the computational process. Then, a modified Manta-Ray Foraging Optimization based on differential evolution used to select the most significant features. The proposed method evaluated using two COVID-19 x-ray datasets. The proposed method achieved accuracy rates of 96.09% and 98.09% for the first and second datasets, respectively.
| S-EPMC7319603 | biostudies-literature
Project description:The existence of widespread COVID-19 infections has prompted worldwide efforts to control and manage the virus, and hopefully curb it completely. One important line of research is the use of machine learning (ML) to understand and fight COVID-19. This is currently an active research field. Although there are already many surveys in the literature, there is a need to keep up with the rapidly growing number of publications on COVID-19-related applications of ML. This paper presents a review of recent reports on ML algorithms used in relation to COVID-19. We focus on the potential of ML for two main applications: diagnosis of COVID-19 and prediction of mortality risk and severity, using readily available clinical and laboratory data. Aspects related to algorithm types, training data sets, and feature selection are discussed. As we cover work published between January 2020 and January 2021, a few key points have come to light. The bulk of the machine learning algorithms used in these two applications are supervised learning algorithms. The established models are yet to be used in real-world implementations, and much of the associated research is experimental. The diagnostic and prognostic features discovered by ML models are consistent with results presented in the medical literature. A limitation of the existing applications is the use of imbalanced data sets that are prone to selection bias.
| S-EPMC8018906 | biostudies-literature
Project description:COVID-19 is the disease evoked by a new breed of coronavirus called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recently, COVID-19 has become a pandemic by infecting more than 152 million people in over 216 countries and territories. The exponential increase in the number of infections has rendered traditional diagnosis techniques inefficient. Therefore, many researchers have developed several intelligent techniques, such as deep learning (DL) and machine learning (ML), which can assist the healthcare sector in providing quick and precise COVID-19 diagnosis. Therefore, this paper provides a comprehensive review of the most recent DL and ML techniques for COVID-19 diagnosis. The studies are published from December 2019 until April 2021. In general, this paper includes more than 200 studies that have been carefully selected from several publishers, such as IEEE, Springer and Elsevier. We classify the research tracks into two categories: DL and ML and present COVID-19 public datasets established and extracted from different countries. The measures used to evaluate diagnosis methods are comparatively analysed and proper discussion is provided. In conclusion, for COVID-19 diagnosing and outbreak prediction, SVM is the most widely used machine learning mechanism, and CNN is the most widely used deep learning mechanism. Accuracy, sensitivity, and specificity are the most widely used measurements in previous studies. Finally, this review paper will guide the research community on the upcoming development of machine learning for COVID-19 and inspire their works for future development. This review paper will guide the research community on the upcoming development of ML and DL for COVID-19 and inspire their works for future development.
| S-EPMC8420483 | biostudies-literature
Project description:BackgroundThe rapid spread of COVID-19 means that government and health services providers have little time to plan and design effective response policies. It is therefore important to quickly provide accurate predictions of how vulnerable geographic regions such as counties are to the spread of this virus.ObjectiveThe aim of this study is to develop county-level prediction around near future disease movement for COVID-19 occurrences using publicly available data.MethodsWe estimated county-level COVID-19 occurrences for the period March 14 to 31, 2020, based on data fused from multiple publicly available sources inclusive of health statistics, demographics, and geographical features. We developed a three-stage model using XGBoost, a machine learning algorithm, to quantify the probability of COVID-19 occurrence and estimate the number of potential occurrences for unaffected counties. Finally, these results were combined to predict the county-level risk. This risk was then used as an estimated after-five-day-vulnerability of the county.ResultsThe model predictions showed a sensitivity over 71% and specificity over 94% for models built using data from March 14 to 31, 2020. We found that population, population density, percentage of people aged >70 years, and prevalence of comorbidities play an important role in predicting COVID-19 occurrences. We observed a positive association at the county level between urbanicity and vulnerability to COVID-19.ConclusionsThe developed model can be used for identification of vulnerable counties and potential data discrepancies. Limited testing facilities and delayed results introduce significant variation in reported cases, which produces a bias in the model.
| S-EPMC7490002 | biostudies-literature
Project description:The coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, is an acute respiratory disease that has been classified as a pandemic by the World Health Organization (WHO). The sudden spike in the number of infections and high mortality rates have put immense pressure on the public healthcare systems. Hence, it is crucial to identify the key factors for mortality prediction to optimize patient treatment strategy. Different routine blood test results are widely available compared to other forms of data like X-rays, CT-scans, and ultrasounds for mortality prediction. This study proposes machine learning (ML) methods based on blood tests data to predict COVID-19 mortality risk. A powerful combination of five features: neutrophils, lymphocytes, lactate dehydrogenase (LDH), high-sensitivity C-reactive protein (hs-CRP), and age helps to predict mortality with 96% accuracy. Various ML models (neural networks, logistic regression, XGBoost, random forests, SVM, and decision trees) have been trained and performance compared to determine the model that achieves consistently high accuracy across the days that span the disease. The best performing method using XGBoost feature importance and neural network classification, predicts with an accuracy of 90% as early as 16 days before the outcome. Robust testing with three cases based on days to outcome confirms the strong predictive performance and practicality of the proposed model. A detailed analysis and identification of trends was performed using these key biomarkers to provide useful insights for intuitive application. This study provide solutions that would help accelerate the decision-making process in healthcare systems for focused medical treatments in an accurate, early, and reliable manner.
| S-EPMC8149622 | biostudies-literature
Project description:Expression of CCR5 and its cognate ligands have been implicated in COVID-19 pathogenesis, consequently therapeutics directed against CCR5 are being investigated. Here, we explored the role of CCR5 and its ligands across the immunologic spectrum of COVID-19. We used a bioinformatics approach to predict and model the immunologic phases of COVID so that effective treatment strategies can be devised and monitored. We investigated 224 individuals including healthy controls and patients spanning the COVID-19 disease continuum. We assessed the plasma and isolated peripheral blood mononuclear cells (PBMCs) from 29 healthy controls, 26 Mild-Moderate COVID-19 individuals, 48 Severe COVID-19 individuals, and 121 individuals with post-acute sequelae of COVID-19 (PASC) symptoms. Immune subset profiling and a 14-plex cytokine panel were run on all patients from each group. B-cells were significantly elevated compared to healthy control individuals (P<0.001) as was the CD14+, CD16+, CCR5+ monocytic subset (P<0.001). CD4 and CD8 positive T-cells expressing PD-1 as well as T-regulatory cells were significantly lower than healthy controls (P<0.001 and P=0.01 respectively). CCL5/RANTES, IL-2, IL-4, CCL3, IL-6, IL-10, IFN-γ, and VEGF were all significantly elevated compared to healthy controls (all P<0.001). Conversely GM-CSF and CCL4 were in significantly lower levels than healthy controls (P=0.01). Data were further analyzed and the classes were balanced using SMOTE. With a balanced working dataset, we constructed 3 random forest classifiers: a multi-class predictor, a Severe disease group binary classifier and a PASC binary classifier. Models were also analyzed for feature importance to identify relevant cytokines to generate a disease score. Multi-class models generated a score specific for the PASC patients and defined as S1 = (IFN-γ + IL-2)/CCL4-MIP-1β. Second, a score for the Severe COVID-19 patients was defined as S2 = (IL-6+sCD40L/1000 + VEGF/10 + 10*IL-10)/(IL-2 + IL-8). Severe COVID-19 patients are characterized by excessive inflammation and dysregulated T cell activation, recruitment, and counteracting activities. While PASC patients are characterized by a profile able to induce the activation of effector T cells with pro-inflammatory properties and the capacity of generating an effective immune response to eliminate the virus but without the proper recruitment signals to attract activated T cells.
| S-EPMC8273732 | biostudies-literature
Project description:The coronavirus is considered this century's most disruptive catastrophe and global concern. This disease has prompted extreme social, psychological and economic impacts affecting millions of people around the globe. COVID-19 is transmitted from one infected person's body to another through respiratory droplets. This virus proliferates when people breathe in air-contaminated space with droplets and microscopic airborne particles. This research aims to analyze automatic COVID-19 detection using machine learning techniques to build an intelligent web application. The dataset has been preprocessed by dropping null values, feature engineering, and synthetic oversampling (SMOTE) techniques. Next, we trained and evaluated different classifiers, i.e., logistic regression, random forest, decision tree, k-nearest neighbor, support vector machine (SVM), ensemble models (adaptive boosting and extreme gradient boosting) and deep learning (artificial neural network, convolutional neural network and long short-term memory) techniques. Explainable AI with the LIME framework has been applied to interpret the prediction results. The hybrid CNN-LSTM algorithm with the SMOTE approach performed better than the other models on the employed open-source dataset obtained from the Israeli Ministry of Health website, with 96.34% accuracy and a 0.98 F1 score. Finally, this model was chosen to deploy the proposed prediction system to a website, where users may acquire an instantaneous COVID-19 prognosis based on their symptoms.
| S-EPMC9876019 | biostudies-literature
Project description:PurposeDifferentiating COVID-19 from other acute infectious pneumonias rapidly is challenging at present. This study aims to improve the diagnosis of COVID-19 using computed tomography (CT).MethodCOVID-19 was confirmed mainly by virus nucleic acid testing and epidemiological history according to WHO interim guidance, while other infectious pneumonias were diagnosed by antigen testing. The texture features were extracted from CT images by two radiologists with 5 years of work experience using modified wavelet transform and matrix computation analyses. The random forest (RF) classifier was applied to identify COVID-19 patients and images.ResultsWe retrospectively analysed the data of 95 individuals (291 images) with COVID-19 and 96 individuals (279 images) with other acute infectious pneumonias, including 50 individuals (160 images) with influenza A/B. In total, 6 texture features showed a positive association with COVID-19, while 4 features were negatively associated. The mean AUROC, accuracy, sensitivity, and specificity values of the 5-fold test sets were 0.800, 0.722, 0.770, and 0.680 for image classification and 0.858, 0.826, 0.809, and 0.842 for individual classification, respectively. The feature 'Correlation' contributed most both at the image level and individual level, even compared with the clinical factors. In addition, the texture features could discriminate COVID-19 from influenza A/B, with an AUROC of 0.883 for images and 0.957 for individuals.ConclusionsThe developed texture feature-based RF classifier could assist in the diagnosis of COVID-19, which could be a rapid screening tool in the era of pandemic.
| S-EPMC7883715 | biostudies-literature
Project description:BackgroundAccurate and timely diagnosis and effective prognosis of the disease is important to provide the best possible care for patients with COVID-19 and reduce the burden on the health care system. Machine learning methods can play a vital role in the diagnosis of COVID-19 by processing chest x-ray images.ObjectiveThe aim of this study is to summarize information on the use of intelligent models for the diagnosis and prognosis of COVID-19 to help with early and timely diagnosis, minimize prolonged diagnosis, and improve overall health care.MethodsA systematic search of databases, including PubMed, Web of Science, IEEE, ProQuest, Scopus, bioRxiv, and medRxiv, was performed for COVID-19-related studies published up to May 24, 2020. This study was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. All original research articles describing the application of image processing for the prediction and diagnosis of COVID-19 were considered in the analysis. Two reviewers independently assessed the published papers to determine eligibility for inclusion in the analysis. Risk of bias was evaluated using the Prediction Model Risk of Bias Assessment Tool.ResultsOf the 629 articles retrieved, 44 articles were included. We identified 4 prognosis models for calculating prediction of disease severity and estimation of confinement time for individual patients, and 40 diagnostic models for detecting COVID-19 from normal or other pneumonias. Most included studies used deep learning methods based on convolutional neural networks, which have been widely used as a classification algorithm. The most frequently reported predictors of prognosis in patients with COVID-19 included age, computed tomography data, gender, comorbidities, symptoms, and laboratory findings. Deep convolutional neural networks obtained better results compared with non-neural network-based methods. Moreover, all of the models were found to be at high risk of bias due to the lack of information about the study population, intended groups, and inappropriate reporting.ConclusionsMachine learning models used for the diagnosis and prognosis of COVID-19 showed excellent discriminative performance. However, these models were at high risk of bias, because of various reasons such as inadequate information about study participants, randomization process, and the lack of external validation, which may have resulted in the optimistic reporting of these models. Hence, our findings do not recommend any of the current models to be used in practice for the diagnosis and prognosis of COVID-19.
| S-EPMC8074953 | biostudies-literature
Project description:This chapter focuses on the application of machine learning algorithms on the diagnosis of the novel coronavirus disease (COVID-19). First, data visualization is provided on increases in confirmed deaths and recovered cases of COVID-19 using currently available data from Johns Hopkins University. Next, the machine learning algorithms are used for the automatic diagnosis of COVID-19. Data-driven diagnosis is performed using a dataset of 5644 samples with 111 attributes provided by Hospital Israelita Albert Einstein, Brazil. As a preprocessing step, null values and categorical data are processed and standardization is performed. Next, feature selection is performed to find attributes that are most important for a COVID-19 diagnosis. A number of algorithms including random forest logistic regression, XGBoost, and decision tree are considered and their kernel parameters are optimized. The performance of classification algorithms is evaluated in terms of a number of factors including the testing accuracy, precision, recall, miss rate, receiver operating characteristic curve and area under the receiver operating characteristic curve. Experimental results show that serum glucose is the most influential attribute in predicting COVID-19. Our results also show that for the case of cross-validation, XGBoost has the highest accuracy value of 92.67% and logistic regressions have the second highest accuracy of 92.58%, whereas both XGBoost and LR have a 93% value for precision, recall, and F1 score. Moreover, for the case of the holdout method with 20% testing data, logistic regression with an accuracy of 94.06% outperforms other classifiers in terms of accuracy, precision, recall, and F1 score.
| S-EPMC8137818 | biostudies-literature